The company has summoned shareholders for April 20 to approve its proposed gross dividend of RON0.003 per share, the equivalent of a 0.6% yield at Thursday’s closing price of RON0.515 per share.
The company plans to set aside RON24 million as reserves.
If the proposal is approved, the health ministry, through which the state owns 53% in Antibiotice Iasi is entitled to RON1.17 million, while RON1.04 million would be distributed among other corporate and individual shareholders.
The company proposes September 20, 2021 for payment and September 3 for registration.